CannabisNewsBreaks Archive - Page 26 of 429

WednesdayMay 17, 2023 11:55 am

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Reports 1,000% Annualized Distribution Channel Growth for New Cannabis Brand

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada -based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, has announced that 8bit, its soon soon-to-be-acquired cannabis brand, is experiencing significant growth. The company noted that 8bit has expanded its active distribution footprint by 30 locations, increasing from 20 stores to 50 stores in just a few weeks. ECGI reports that is a 150% increase in distribution footprint in less than two months, which tops 1,000% annualized growth in distribution footprint over the same period. In March, ECGI entered a binding letter of intent to acquire the key personnel,…

TuesdayMay 16, 2023 3:03 pm

CannabisNewsBreaks – AmeriCann Inc. (ACAN) Reports Best-Ever Revenue, Net Income

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, is reporting on its financial and operational results for the quarter ending March 2023; the report showed the company’s best-ever annual revenue and net income for its latest four quarters. According to the report, AmeriCann has reported five consecutive quarters of positive net income, with net income increasing 257% and revenue increasing an estimated 12% for the quarter ended March 2023 compared to the quarter ended March 2022. In the report, the company attributed the increased revenue to products produced and manufactured at the company's…

MondayMay 15, 2023 3:34 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment in our phase 2 clinical trial for epidermolysis bullosa, marking the first time cannabinol (‘CBN’) has completed a phase 2 clinical trial. We look forward to the data read out during 3Q and will then…

FridayMay 12, 2023 1:14 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced the closing of its public offering of 2,106,000 units, with each consisting of one share of common stock and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.95. The warrants are immediately exercisable at a price of $0.95 per share and expire five years from the date of issuance. The shares of common stock and accompanying warrants were only purchasable together in the offering but were issued separately and immediately separable upon issuance. Gross proceeds…

ThursdayMay 11, 2023 2:55 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by the Food and Drug Administration (“FDA”). Filling into capsules is expected to be completed this month. This will follow with analytical release and stability testing in order to gather essential quality control data necessary for…

WednesdayMay 10, 2023 2:29 pm

CannabisNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry thought leaders, and 3,000 to 5,000 growers, licensed producers, retailers, budtenders, investors and consumers. As a fifth year of cannabis legalization in Canada comes to fruition, the event will commence with the full-day Lift Cannabis…

WednesdayMay 10, 2023 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company's issued share capital as of the meeting date of March 13, 2023. The matters voted upon and the final voting results are set forth as detailed in the announcement. All proposals are described in detail in Lexaria’s proxy statement filed with the Securities…

TuesdayMay 09, 2023 1:40 pm

CannabisNewsBreaks – Alternative Products Expo Slated to Return to Medellín for Upcoming Two-Day Event

The Alternative Products Expo, produced by ZJ Events, is being held this year for two days in Medellín, Colombia. Slated for May 20–21, 2023, the conference will feature an estimated 200 companies exhibiting more than 1,000 products in the alternative products space. Medellín, which hosted the expo in 2017 as well, offers an ideal location for the conference, which is designed to provide attendees with key information from the alternative-products space as well as invaluable networking opportunities. The event has become the largest expo series for all things vape, hemp and counterculture, and is a key gathering for smoke-shop owners,…

MondayMay 08, 2023 3:04 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery…

FridayMay 05, 2023 10:43 am

CannabisNewsBreaks – BizCann Expo Shares Agenda Details for Upcoming Colombian Cannabis Expo

BizCann Expo, hosted by ZJ Events, is gearing up for its next event to be held May 21–22, 2023, in Medellín, Colombia. A premier cannabis event in South and Latin America, BizCann is designed to provide key information on innovation, entrepreneurship, and education on all aspects of the cannabis sector. This year’s two-day agenda features an impressive array of presentations from more than 20 speakers, including 3C Consulting founder and CEO Nic Easley, GNC-Brands founder Juan Gonzalez, Global Cannabis Network Collective business developer Rosa Maria Puentes Velosa and Green Leaf Colombia cofounder and production manager Camilo Martínez. The event is…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks